publication venue for
- Correction to: Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real‑world, multi‑center, matched analysis. 2022
- Interventional antibiotic treatment replacing antibiotic prophylaxis during allogeneic hematopoietic stem cell transplantation is safe and leads to a reduction of antibiotic administration. 2024
- A randomized, double-blind, placebo-controlled phase 3 study to assess efficacy and safety of ropeginterferon alfa-2b in patients with early/lower-risk primary myelofibrosis. 2024
- The occurrence of thrombosis during intensive chemotherapy treatment for acute myeloid leukemia patients does not impact on long-term survival.. 102. 2023
- Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real-world, multi-center, matched analysis.. 101. 2022
- Evaluating outcomes of adult patients with acute lymphoblastic leukemia and lymphoblastic lymphoma treated on the GMALL 07/2003 protocol.. 101. 2022
- ELN 2017 classification significantly impacts the risk of early death in acute myeloid leukemia patients receiving intensive induction chemotherapy.. 101. 2022
- Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study. 2021
- Gastrointestinal toxicity of high-dose melphalan in autologous hematopoietic stem cell transplantation: identification of risk factors and a benchmark for experimental therapies.. 100. 2021
- An assessment of the continuing medical education needs of US physicians in the management of patients with beta thalassemia.. 100. 2020
- Modified BuCy is an alternative conditioning regimen for lymphoma patients undergoing autologous stem cell transplantation.. 98. 2019
- Neutrophil to lymphocyte ratio (NLR) improves the risk assessment of ISS staging in newly diagnosed MM patients treated upfront with novel agents.. 94. 2015
- Clinical response to ruxolitinib in CSF3R T618-mutated chronic neutrophilic leukemia.. 95. 2016
- Antibody to a high-prevalence blood group antigen Ata associated with Sjögren's syndrome.. 87. 2007
- Extramedullary hemopoiesis with littoral cell angioma involving main and accessory spleens.. 86. 2007
- Cystatin F a potential diagnostic biomarker in acute promyelocytic leukemia. 2024
- Cytogenetically cryptic insertion of PML segment into RARA on chromosome 17q resulting PML-RARA fusion in acute promyelocytic leukemia. 2018
- Management of chronic myeloid leukemia in blast crisis. 2015
- Diagnosis and management of chronic ITP: comments from an ICIS expert group. 2010
- Treatment with midostaurin and other FLT3 targeting inhibitors is associated with an increased risk of cardiovascular adverse events in patients who underwent allogeneic hematopoietic stem cell transplantation with FLT3-mutated AML. 2023
- Programmed cell death-1 pathway inhibition in myeloid malignancies: implications for myeloproliferative neoplasms. 2017
- Primary myelofibrosis and its targeted therapy. 2016